Offer - Urjas Oil for just ₹ 1 X
Celonib, a prescription drug, is manufactured in various forms such as Capsule. It is primarily used for the treatment of Chronic Myelogenous Leukemia. The alternative uses of Celonib have also been explained below.
The optimal dosage of Celonib is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
Some other side effects of Celonib have been listed ahead. Such side effects of Celonib normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Celonib is Severe for pregnant women and Moderate for women who are breastfeeding. In addition, Celonib's effects on the liver, heart and kidney are discussed below in the Celonib related warnings section.
The section on Celonib contraindications lists all such conditions.
Additionally, Celonib may also adversely react with other medicines. See below for a complete list.
In addition to the above precautions for Celonib, it is important to know that it is not safe while driving, and is not habit-forming.
Celonib is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
2 - 12 years (Child) |
|
13 - 18 years (Adolescent) |
|
Is the use of Celonib safe for pregnant women?
Pregnant women may get severe side effects after taking Celonib. If you are pregnant, do not take Celonib without a doctor's advice.
Is the use of Celonib safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Celonib. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Celonib on the Kidneys?
Celonib may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Celonib on the Liver?
Celonib may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Celonib on the Heart?
There may be an adverse effect on the heart after taking Celonib. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
Celonib should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Celonib unless your doctor advises you to do so -
Is this Celonib habit forming or addictive?
No, there is no any evidence that Celonib is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Celonib can make you feel drowsy.
Is it safe?
Celonib is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Celonib is unable to treat or cure mental disorders.
Interaction between Food and Celonib
Taking Celonib with food is safe.
Interaction between Alcohol and Celonib
Due to lack of research, there is no information about the side effects of taking Celonib with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Gleevec (imatinib mesylate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 674-676
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 869